P-GLYCOPROTEIN AND DRUG-RESISTANCE IN ACUTE LEUKEMIAS AND IN THE BLASTIC CRISIS OF CHRONIC MYELOID-LEUKEMIA

被引：0
作者：
CARULLI, G
PETRINI, M
MARINI, A
VAGLINI, F
CARACCIOLO, F
GRASSI, B
机构：
[1] UNIV PISA,MED CLIN 1,UNITA EMATOL,I-56100 PISA,ITALY
[2] UNIV PISA,IST FARMACOL,I-56100 PISA,ITALY
来源：
HAEMATOLOGICA | 1990年 / 75卷 / 06期
关键词：
CHEMORESISTANCE; LEUKEMIA; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; P-170;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The aim of this work is to evaluate the relationship between P-glycoprotein expression in circulating blasts and clinical response in patients suffering from acute lymphoblastic leukemia, acute non-lymphoblastic leukemia, and chronic myeloid leukemia in either lymphoid or myeloid blastic crisis. The results obtained show that: a) patients whose blasts express P-glycoprotein are resistant towards protocols including Doxorubicin, Daunorubicin, Etoposide, Mithramycin, Vincristine; b) P-glycoprotein can be expressed constitutively in some cases; c) P-glycoprotein does not appear to be the only mechanism responsible for resistance towards anthracyclines and Etoposide.
引用
收藏
页码：516 / 521
页数：6
相关论文
共 50 条
  • [41] Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
    Maia, Raquel C.
    Vasconcelos, Flavia C.
    Souza, Paloma S.
    Rumjanek, Vivian M.
    MOLECULES, 2018, 23 (01):
  • [42] Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib
    Stromskaya, T. P.
    Rybalkina, E. Yu.
    Kruglov, S. S.
    Zabotina, T. N.
    Mechetner, E. B.
    Turkina, A. G.
    Stavrovskaya, A. A.
    BIOCHEMISTRY-MOSCOW, 2008, 73 (01) : 29 - 37
  • [43] Mechanisms of drug resistance in acute myeloid leukemia
    Zhang, Jing
    Gu, Yan
    Chen, Baoan
    ONCOTARGETS AND THERAPY, 2019, 12 : 1937 - 1945
  • [44] Quantification of P-glycoprotein in chronic lymphocytic leukemia by flow cytometry
    Maynadie, M
    Matutes, E
    Catovsky, D
    LEUKEMIA RESEARCH, 1997, 21 (09) : 825 - 831
  • [45] P-glycoprotein expression in adult acute myeloid leukemia:: correlation with induction treatment outcome
    Tóthová, E
    Elbertová, A
    Fricová, M
    Kafková, A
    Hlebasková, A
    Svorcová, E
    Stecová, N
    Guman, T
    Raffac, S
    NEOPLASMA, 2001, 48 (05) : 393 - 397
  • [46] Repetitive analyses of P-glycoprotein in chronic myeloid leukaemia
    De Moerloose, B
    Muylaert, A
    Gemmel, F
    Janssens, A
    Poppe, B
    Dhooge, C
    Benoit, Y
    Van Hove, W
    Philippé, J
    ACTA CLINICA BELGICA, 2000, 55 (04): : 215 - 221
  • [47] Evidence of a role for functional heterogeneity in multidrug resistance transporters in clinical trials of P-glycoprotein modulation in acute myeloid leukemia
    Marcelletti, John F.
    Sikic, Branimir I.
    Cripe, Larry D.
    Paietta, Elisabeth
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2019, 96 (01) : 57 - 66
  • [48] The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line
    Zhang, Yang-Yang
    Xie, Ke-Ming
    Yang, Guo-Qing
    Mu, Hui-Jun
    Yin, Ying
    Zhang, Bin
    Xie, Ping
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 361 - 367
  • [49] Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: Impact of antibodies, sample source and disease status
    Filipits, M
    Suchomel, RW
    Lechner, K
    Pirker, R
    LEUKEMIA, 1997, 11 (07) : 1073 - 1077
  • [50] Immunocytochemical detection of the multidrug resistance-associated protein and P-glycoprotein in acute myeloid leukemia: impact of antibodies, sample source and disease status
    M Filipits
    RW Suchomel
    K Lechner
    R Pirker
    Leukemia, 1997, 11 : 1073 - 1077
12345